Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Epilepsy D004827 35 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Birth Weight D001724 23 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Ear Diseases D004427 7 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Agranulocytosis D000380 7 associated lipids
Shock D012769 11 associated lipids
Polycythemia Vera D011087 13 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Fever D005334 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Spasm D001986 18 associated lipids
Shock, Septic D012772 11 associated lipids
Immune Complex Diseases D007105 9 associated lipids
Conjunctivitis D003231 7 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Death, Sudden D003645 12 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Neutropenia D009503 15 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Meningioma D008579 11 associated lipids
Multiple Trauma D009104 2 associated lipids
Cluster Headache D003027 4 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Migraine Disorders D008881 11 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Hines KL and Fisher RA Regulation of hepatic glycogenolysis and vasoconstriction during antigen-induced anaphylaxis. 1992 Am. J. Physiol. pmid:1375439
Livio M et al. Role of platelet-activating factor in primary hemostasis. 1988 Am. J. Physiol. pmid:2837916
Zimmerman BJ et al. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. 1994 Am. J. Physiol. pmid:8160832
Del Maschio A et al. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. 1990 Am. J. Physiol. pmid:2156456
DeFily DV et al. PAF attenuates endothelium-dependent coronary arteriolar vasodilation. 1996 Am. J. Physiol. pmid:8764261
Munoz NM et al. Effects of PAF on isolated rat airways perfused with blood-free solution. 1991 Am. J. Physiol. pmid:2018147
Yamazaki M et al. Modulation of leukotriene B4 and platelet-activating factor binding to neutrophils. 1991 Am. J. Physiol. pmid:1653524
Hasunuma K et al. Endothelin 1 causes pulmonary vasodilation in rats. 1990 Am. J. Physiol. pmid:2115743
Schlondorff D et al. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells. 1986 Am. J. Physiol. pmid:3087218
Wallace JL et al. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock. 1990 Am. J. Physiol. pmid:2372058
Kurose I et al. Microvascular dysfunction induced by nonsteroidal anti-inflammatory drugs: role of leukocytes. 1996 Am. J. Physiol. pmid:8779980
Gozal D et al. Platelet-activating factor modulates cardiorespiratory responses in the conscious rat. 1998 Am. J. Physiol. pmid:9688699
Suzuki M et al. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. 1998 Am. J. Physiol. pmid:9458712
Owen CA et al. Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity. 1997 Am. J. Physiol. pmid:9124593
Harris NR et al. Capillary filtration during acute inflammation: role of adherent neutrophils. 1993 Am. J. Physiol. pmid:7902014
Ardaillou N et al. Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. 1985 Am. J. Physiol. pmid:3918460
Zhou W et al. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats. 1992 Am. J. Physiol. pmid:1443133
Bussolino F et al. Platelet activating factor induces dopamine release in PC-12 cell line. 1988 Am. J. Physiol. pmid:3177629
Sun X et al. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. 1997 Am. J. Physiol. pmid:9252509
Saito M et al. Association of granular exocytosis with Ca(2+)-activated K+ channels in human eosinophils. 1997 Am. J. Physiol. pmid:9252535
Gulbins E et al. Effects of rC5a on the circulation of normal and split hydronephrotic rat kidneys. 1993 Am. J. Physiol. pmid:8342619
Sánchez-Crespo M et al. Presence in normal human urine of a hypotensive and platelet-activating phospholipid. 1983 Am. J. Physiol. pmid:6859262
Rabe KF et al. Contraction of human bronchial smooth muscle caused by activated human eosinophils. 1994 Am. J. Physiol. pmid:7943259
Kobayashi I et al. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C. 1994 Am. J. Physiol. pmid:8160825
Arnould T et al. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. 1993 Am. J. Physiol. pmid:8098907
Shibamoto T et al. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs. 1993 Am. J. Physiol. pmid:8498559
Miller MJ et al. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. 1988 Am. J. Physiol. pmid:2847541
Miura S et al. Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid. 1993 Am. J. Physiol. pmid:8498509
Faden AI and Tzendzalian PA Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma. 1992 Am. J. Physiol. pmid:1415805
Chami O et al. Components of a platelet-activating factor-signaling loop are assembled in the ovine endometrium late in the estrous cycle. 2004 Am. J. Physiol. Endocrinol. Metab. pmid:15271646
Cheng L et al. A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice. 2009 Am. J. Physiol. Endocrinol. Metab. pmid:19773578
Parkman HP et al. The contractile action of platelet-activating factor on gallbladder smooth muscle. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10898747
Ma J et al. ATP: a mediator for HCl-induced TRPV1 activation in esophageal mucosa. 2011 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:21960521
Guarino MP et al. PAF-like lipids- and PAF-induced gallbladder muscle contraction is mediated by different pathways in guinea pigs. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12936911
Si J et al. STAT5 mediates PAF-induced NADPH oxidase NOX5-S expression in Barrett's esophageal adenocarcinoma cells. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:17947454
Cheng L et al. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. 2005 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15890711
Wang GD et al. Platelet-activating factor in the enteric nervous system of the guinea pig small intestine. 2006 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:17030900
Claud EC et al. Platelet-activating factor-induced chloride channel activation is associated with intracellular acidosis and apoptosis of intestinal epithelial cells. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:18339705
Liu SX et al. Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice. 2009 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19460845
Lu J et al. Platelet-activating factor-induced apoptosis is blocked by Bcl-2 in rat intestinal epithelial cells. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:14512286
Rozenfeld RA et al. Role of gut flora on intestinal group II phospholipase A2 activity and intestinal injury in shock. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11557516
Cheng L et al. HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa. 2009 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19389802
Lautenschläger I et al. A model of the isolated perfused rat small intestine. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19910525
Lu J et al. Polyunsaturated fatty acids block platelet-activating factor-induced phosphatidylinositol 3 kinase/Akt-mediated apoptosis in intestinal epithelial cells. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:18356536
Ma J et al. Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19959817
Han XB et al. Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15319184
Rieder F et al. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:20299604
Oktar BK et al. Endothelin-1-induced PMN infiltration and mucosal dysfunction in the rat small intestine. 2000 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:10960346
Thom SR et al. Roles for platelet-activating factor and *NO-derived oxidants causing neutrophil adherence after CO poisoning. 2001 Am. J. Physiol. Heart Circ. Physiol. pmid:11454599
Juchem G et al. Regulation of coronary venular barrier function by blood borne inflammatory mediators and pharmacological tools: insights from novel microvascular wall models. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22081707